BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 1010180)

  • 1. [The hypotensive effect of propranolol: pathophysiological and clinical approach (author's transl)].
    Pessina AC; Corgnati A; Palù CD
    G Ital Cardiol; 1976; 6(2):290-9. PubMed ID: 1010180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metoprolol in high renin hypertension. A comparison with propranolol.
    Lameyer LD; Hesse CJ
    Ann Clin Res; 1981; 13 Suppl 30():16-22. PubMed ID: 7027889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of essential hypertension with propranolol (author's transl)].
    Klumpp F; Braun B; Klaus D; Lemke R; Zehner J
    Dtsch Med Wochenschr; 1976 Oct; 101(41):1482-8. PubMed ID: 183943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Propranolol, renin and hypertension: a review.
    Laragh JH; Bühler FR
    Postgrad Med J; 1976; 52 Suppl 4(604):109-15. PubMed ID: 787950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haemodynamic consequences of intrinsic sympathomimetic activity in relation to changes in plasma renin activity and noradrenaline during beta-blocker therapy for hypertension.
    Man in't Veld AJ; Schalekamp MA
    Postgrad Med J; 1983; 59 Suppl 3(689):140-58. PubMed ID: 6139800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Relations between hypotensive effect and modifications of volemia and plasma renin activity in patients with essential hypertension treated using spironolactone].
    Pessina AC; Corgnati A; Palù CD
    Minerva Med; 1977 Feb; 68(8):509-14. PubMed ID: 846681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relative roles of sodium and renin in the hypertension of renal disease. An assessment based on the response to frusemide and propranolol.
    Wilkinson R; Sellars L; Pickering M; Robson V; Kerr DN
    Clin Nephrol; 1981 Dec; 16(6):307-13. PubMed ID: 7032775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Observations of the role of body fluid volumes and plasma renin activity in the management of hypertension.
    Dorhout Mees EJ; Geyskes GG; Vos J; Boer P
    Arch Int Pharmacodyn Ther; 1975 Apr; 214(2):335-46. PubMed ID: 1156038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of diazoxide on blood pressure, PRA and plasma aldosterone in hypertensive patients (author's transl)].
    Mantero F; Perini A; Armanini D; Gion M; Opocher G; Boscaro M
    G Ital Cardiol; 1976; 6(7):1246-53. PubMed ID: 1010235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of drug concentration measurements in studies of the therapeutic response to propranolol.
    Chidsey C; Pine M; Favrot L; Smith S; Leonetti G; Morselli P; Zanchetti A
    Postgrad Med J; 1976; 52 Suppl 4():26-32. PubMed ID: 967771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hemodynamic changes under metoprolol compared to propranolol in hypertensive patients].
    Pfisterer M; Burkart F; Bühler FR; Schweizer W
    Schweiz Med Wochenschr; 1976 Nov; 106(45):1567-9. PubMed ID: 1013675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proposed mechanisms of propranolol's antihypertensive effect in essential hypertension.
    Hollifield JW; Sherman K; Zwagg RV; Shand DG
    N Engl J Med; 1976 Jul; 295(2):68-73. PubMed ID: 775330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of propranolol on spontaneous and experimental hypertension in the rat.
    Pessina AC; Corgnati A; Palatini P; Oneglia C; Palu CD
    Clin Sci Mol Med Suppl; 1976 Dec; 3():447s-450s. PubMed ID: 1071662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control plasma renin activity and changes in sympathetic tone as determinants of minoxidil-induced increase in plasma renin activity.
    O'Malley K; Velasco M; Wells J; McNay JL
    J Clin Invest; 1975 Feb; 55(2):230-5. PubMed ID: 1127099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypotensive and renin-suppressing activities of propranolol in hypertensive patients.
    Leonetti G; Mayer G; Morganti A; Terzoli L; Zanchetti A; Bianchetti G; Di Salle E; Morselli PL; Chidsey CA
    Clin Sci Mol Med Suppl; 1975 Jun; 48(6):491-9. PubMed ID: 1056279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of propranolol on diuretic activity of furosemide hypertensive patients (author's transl)].
    Imbs JL; Spach MO; Schmidt M; Bloch R; Schwartz J
    Nephrologie; 1981; 2(4):184-8. PubMed ID: 7035987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Behavior of blood volume and electrolytes in patients with essential hypertension with low plasmatic renin activity (PRA). Effects of treatment with propranolol].
    Aguglia F; Santucci A; Cicconetti P; Federico M; Caputo V; Balsano F
    Boll Soc Ital Cardiol; 1978; 23(8):1340-8. PubMed ID: 398712
    [No Abstract]   [Full Text] [Related]  

  • 18. New concepts of the renin system and of vasoconstriction-volume mechanisms. Diagnosis and treatment of renovascular and renal hypertensions.
    Vaughan EF; Laragh JH
    Urol Clin North Am; 1975 Jun; 2(2):237-57. PubMed ID: 1098253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of obzidan on hemodynamic indices and the renin and aldosterone levels of the blood plasma in patients with juvenile hypertension].
    Zanozdra NS; Chernoguz LS; Kupchinskaia SG; Primak GF; Korchinskaia OI
    Vrach Delo; 1989 Jun; (6):41-3. PubMed ID: 2675468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renin and beta-blockade: prorenin and aldosterone may explain the controversy.
    McKenna F; Davison AM
    Clin Nephrol; 1986 Mar; 25(3):149-54. PubMed ID: 2869848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.